CVS Group (LON:CVSG) Earns Outperform Rating from Royal Bank Of Canada

CVS Group (LON:CVSG)‘s stock had its “outperform” rating restated by equities research analysts at Royal Bank Of Canada in a report released on Friday, Marketbeat reports. They currently have a GBX 1,500 price target on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 22.15% from the company’s previous close.

Separately, Berenberg Bank restated a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a report on Thursday, July 24th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, CVS Group currently has an average rating of “Buy” and an average target price of GBX 1,750.

CVS Group Price Performance

LON CVSG opened at GBX 1,228 on Friday. CVS Group has a fifty-two week low of GBX 791 and a fifty-two week high of GBX 1,342. The stock’s 50-day moving average is GBX 1,234.84 and its two-hundred day moving average is GBX 1,155.01. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. The firm has a market cap of £880.97 million, a P/E ratio of 32,315.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02.

Insider Activity

In other CVS Group news, insider Richard Fairman purchased 1,644 shares of the stock in a transaction dated Friday, July 11th. The shares were bought at an average cost of GBX 1,216 per share, with a total value of £19,991.04. Also, insider David Wilton purchased 1,000 shares of the stock in a transaction dated Monday, June 2nd. The stock was acquired at an average cost of GBX 1,248 per share, for a total transaction of £12,480. Company insiders own 1.37% of the company’s stock.

About CVS Group

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.